NCT06990724 Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.
| NCT ID | NCT06990724 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Contraceptive Usage |
| Study Type | INTERVENTIONAL |
| Enrollment | 850 participants |
| Start Date | 2025-06-11 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 850 participants in total. It began in 2025-06-11 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effectiveness of a videogame compared to an attention/time control at reducing contraceptive non-use among adolescents.
Eligibility Criteria
Inclusion Criteria: * Male or Female * Age15-20 at the time of enrollment * Able to speak and read English or Spanish * Have a smart phone (to scan QR code) or personal email account (to take screening questionnaire) Exclusion Criteria: * Age less than 15 or older than 20 * Unable to speak and read English or Spanish * Do not have a smart phone or personal email account
Contact & Investigator
Aileen Gariepy, MD, MPH, MHS
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT06990724 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 20 Years, studying Contraceptive Usage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06990724 currently recruiting?
Yes, NCT06990724 is actively recruiting participants. Contact the research team at mir4017@med.cornell.edu for enrollment information.
Where is the NCT06990724 trial being conducted?
This trial is being conducted at Brooklyn, United States, New York, United States, Queens, United States, Staten Island, United States and 3 additional locations.
Who is sponsoring the NCT06990724 clinical trial?
NCT06990724 is sponsored by Weill Medical College of Cornell University. The principal investigator is Aileen Gariepy, MD, MPH, MHS at Weill Medical College of Cornell University. The trial plans to enroll 850 participants.